
New research suggests that digital breast tomosynthesis (DBT) offers significantly higher detection rates than digital mammography for radial sclerosing lesions, lobular carcinoma in situ and atypical lobular hyperplasia.
Senior Editor, Diagnostic Imaging

New research suggests that digital breast tomosynthesis (DBT) offers significantly higher detection rates than digital mammography for radial sclerosing lesions, lobular carcinoma in situ and atypical lobular hyperplasia.

Greater calcified plaque volume, quantified with AI assessment of carotid CTA, was associated with more than double the likelihood of obstructive coronary artery disease (OCAD), according to newly published research.

Catch up on the top radiology content of the past week.

Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.

The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.

The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.

In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.

A high glandular tissue component on pre-op breast ultrasound may significantly elevate the risk of recurrence for ipsilateral or contralateral breast cancer, according to a newly published study.

Effective January 1, 2027, use of the QTscan in outpatient diagnostic exams will be reimbursable with the CPT code 1079T.

In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.

Catch up on the top radiology content of the past week.

In a recent interview, Gadi Lalazar, MD, discussed new research demonstrating the capability of natural language processing (NLP) to enhance recognition of incidental hepatic steatosis in ultrasound reports.

Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.

Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.

While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.

The Evident Vascular Guidance System and Evident peripheral imaging catheters reportedly offer enhanced image clarity and workflow efficiencies for intravascular ultrasound.

New research found that the late arterial phase, which accounts for approximately 40 percent of CT radiation dosing in cases involving acute abdominal pain, offered no exclusive findings that had an impact on clinical care.

New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.

In a recent podcast episode, Jack Andrews, MD, discussed the role of PSMA PET in facilitating more targeted, metastasis-directed therapy for prostate cancer and recent phase 4 research comparing PSMA PET agents in men with low PSA values.

Catch up on the top radiology content of the past week.

In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),

Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).

In a new podcast episode, Sharmila Dorbala, MD, MPH, shares her insights on recently published phase 3 research examining the use of the PET/CT radiotracer 124I-evuzamitide for bolstering detection of cardiac amyloidosis.

In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, offers pertinent insights into a recent study assessing whether AI models for breast cancer detection and short-term risk prediction can be used interchangeably.

In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, discusses recently published guidelines on proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).

In the second of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, discussed the possible impact of new research showing significant declines in CT radiation dosing over the past decade, future research directions and the potential for indication-based diagnostic reference levels (DRLs) in the future.

In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, reviews key findings from a recent study examining the utility of contrast-enhanced mammography in prevalence and screening rounds.

In the first of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, reviewed key findings from a study examining CT radiation dosing over the past decade and shared insights from their experience for ensuring optimal radiation dosing for CT scans.

The AI-powered NeuroDR software reportedly removes bone, soft tissue and veins from CTA scans and provides subsequent 3D MIP views and curved planar reformatted views of carotid and vertebral arteries.

In a recent interview with Diagnostic Imaging, Eliad Josephson discussed key attributes of the HLTH USA conference, AI trends and an ongoing shift of emphasis on the development of predictive technologies with diagnostics at center stage.

Published: February 21st 2026 | Updated: February 23rd 2026

Published: November 27th 2024 | Updated: December 4th 2024

Published: October 15th 2024 | Updated: October 16th 2024

Published: May 6th 2024 | Updated: May 8th 2024

April 22nd 2022